(311.51 KB, 458x575)
(126.88 KB, 1284x1179)
(122.25 KB, 843x914)
(116.8 KB, 653x465)
>>/11423/ Research articles on myocarditis, 2006 - 2012 plus current wiki SEE BELOW There may be more, but i get the impression that this area is not very well-researched, perhaps because until now, the condition was rare. But the stupid twit/article maintained that Covid-19 myocarditis is "different" from earlier kinds. I spozed that's really all they can do, isn't it? To say it's a lighter, brighter kind of myocarditis. Outta the hospital in just four to six days! (But look at the sample sizes) They totally glossed over everything in that June CDC meeting - the slide show is a joke. The Israeli study must have caused them problems because it's bigger and did have at least 5% of people with SERIOUS myocarditis,even short-term. The fact that vaxxed athletes are dropping dead right and left suggests that the biggest problem may be with SUB-CLINICAL manifestations. Person feels fine until they EXERCISE VIGOROUSLY. For the last time, kek. So the idea that most people don't have symptoms isn't gonna help in the long run. The ABSENCE of symptoms just means the vax is a ticking time bomb, set to go off after extreme exertion. --The article cited by everybody mentioning the lousy five-year prognosis is from 2012: -- Myocarditis: Early Biopsy Allows for Tailored Regenerative Treatment May 2012 Prognosis: Acute myocarditis mostly does not sufficiently respond to symptomatic medication for heart failure, and mortality is high in spite of treatment. The long-term disease course depends on the pathogen, the extent and type of inflammation, and the initial injury to the myocardium. Focal borderline myocarditis often undergoes spontaneous clinical healing if no serious heart failure developed initially. The early mortality of fulminant lymphocytic myocarditis requiring intensive care is in excess of 40% in the first 4 weeks (7). Untreated giant cell and eosinophilic myocarditis also have an extremely poor prognosis, with 4 year survival rates of less than 20% (8). Granulomatous necrotizing myocarditis is lethal if overlooked and untreated. Non-fulminant active myocarditis has a mortality rate of 25% to 56% within 3 to 10 years, owing to progressive heart failure and sudden cardiac death, especially if symptomatic heart failure manifests early on (9– 11, e1). In addition to impaired left ventricular (LV) and right ventricular (RV) function, virus persistence, chronic inflammation, and cardiodepressive autoantibodies are independent predictors of a poor prognosis (9, 12, 13). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3370379/ There are earlier articles from 2006 and 2007: Myocarditis: Current Trends in Diagnosis and Treatment https://www.ahajournals.org/doi/full/10.1161/circulationaha.105.584532 Myocarditis is the end result of both myocardial infection and autoimmunity that results in active inflammatory destruction of myocytes. Its precise characterization and natural history have been limited by the extraordinary variability of its clinical presentations, laboratory findings, and the diversity of etiologies...."Treatment of myocarditis in 2006 remains largely supportive. Immunosuppression has not been shown to be effective as routine treatment for acute lymphocytic myocarditis. Early trials of antiviral therapies, such as interferons, suggest a potential therapeutic role but require further investigation Indicators of Poor Prognosis of Acute Pericarditis https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.106.662114 The clinical search for indicators of poor prognosis of acute pericarditis may be useful for clinical triage of patients at high risk of specific causal conditions or complications.... page 1